Fleuren, E. D., Hillebrandt-Roeffen, M. H., Flucke, U. E., te Loo, D. M. W., Boerman, O. C., van der Graaf, W. T., & Versleijen-Jonkers, Y. M. (2014). The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma. Oncotarget.
Citação norma ChicagoFleuren, Emmy D.G., Melissa H.S Hillebrandt-Roeffen, Uta E. Flucke, D. Maroeska W.M te Loo, Otto C. Boerman, Winette T.A van der Graaf, and Yvonne M.H Versleijen-Jonkers. "The Role of AXL and the in Vitro Activity of the Receptor Tyrosine Kinase Inhibitor BGB324 in Ewing Sarcoma." Oncotarget 2014.
Citação norma MLAFleuren, Emmy D.G., et al. "The Role of AXL and the in Vitro Activity of the Receptor Tyrosine Kinase Inhibitor BGB324 in Ewing Sarcoma." Oncotarget 2014.